AC Immune SA
ACIU
$2.29
-$0.08-3.38%
Headlines
4/5/2024
-
Simply Wall St
4/2/2024
-
Zolmax
3/19/2024
-
Zolmax
3/19/2024
-
Tickeron - Stocks
3/18/2024
-
Ticker Report
3/15/2024
-
Simply Wall St
3/15/2024
-
Tickeron - Stocks
3/15/2024
-
Tickeron - Stocks
3/15/2024
-
Tickeron - Stocks
3/15/2024
-
Tickeron - Stocks
3/15/2024
-
InvestorPlace
3/14/2024
-
The Fly
3/14/2024
-
The Fly
3/14/2024
-
The Fly
3/14/2024
-
Globe Newswire
3/14/2024
-
Tickeron - Stocks
3/13/2024
-
Tickeron - Stocks
3/12/2024
-
Zolmax
3/12/2024
-
Tickeron - Stocks
3/12/2024
-
Tickeron - Stocks
3/11/2024
-
TipRanks Financial Blog
3/6/2024
-
Tickeron - Stocks
3/6/2024
-
Tickeron - Stocks
3/5/2024
-
Tickeron - Stocks
Filings
Thursday, March 14, 2024
Sunday, December 31, 2023
Week of Apr 22 and 26 (est)
Price History
Business Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases...
more